Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-027846
Filing Date
2025-07-29
Accepted
2025-07-29 16:58:07
Documents
26
Period of Report
2025-09-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20049997x1_def14a.htm   iXBRL DEF 14A 1598455
6 GRAPHIC logo_roivant02.jpg GRAPHIC 34616
7 GRAPHIC logo_roivant02x1.jpg GRAPHIC 32659
8 GRAPHIC ny20049997x1_barchart01.jpg GRAPHIC 121807
9 GRAPHIC ny20049997x1_barchart02.jpg GRAPHIC 129547
10 GRAPHIC ny20049997x1_barchart03.jpg GRAPHIC 134867
11 GRAPHIC ny20049997x1_barchart04.jpg GRAPHIC 118865
12 GRAPHIC ny20049997x1_image01.jpg GRAPHIC 4448
13 GRAPHIC ny20049997x1_image02.jpg GRAPHIC 4273
14 GRAPHIC ny20049997x1_pc01.jpg GRAPHIC 748114
15 GRAPHIC ny20049997x1_pc02.jpg GRAPHIC 584253
  Complete submission text file 0001140361-25-027846.txt   7179753

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA roiv-20250910.xsd EX-101.SCH 3289
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE roiv-20250910_def.xml EX-101.DEF 1947
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE roiv-20250910_lab.xml EX-101.LAB 1944
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE roiv-20250910_pre.xml EX-101.PRE 2231
28 EXTRACTED XBRL INSTANCE DOCUMENT ny20049997x1_def14a_htm.xml XML 145456
Mailing Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB
Business Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-40782 | Film No.: 251162659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)